Immatics (IMTX) Current Taxes (2024 - 2025)
Immatics' (IMTX) quarterly Current Taxes came in at $2.7 million in Q4 2025, up 43.39% year-on-year from $1.9 million in Q4 2024, and up 43.39% quarter-over-quarter from $1.9 million in Q4 2024.
Immatics (IMTX) Current Taxes (2024 - 2025) Analysis & Trends
Immatics has disclosed Current Taxes across 2 years of filings, most recently posting $2.7 million for Q4 2025.
- Current Taxes for Q4 2025 came in at $2.7 million, up 43.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.7 million (up 43.39% YoY), and the FY2025 annual result was $2.6 million, up 39.17% from the prior year.
- Current Taxes came in at $2.7 million for Q4 2025 at Immatics, up from $1.9 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $2.7 million in Q4 2025 to a low of $1.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 2.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | 1.88 Mn |